Guinea-Bissau vs Indonesia: Prevalence rate of hypertension in men aged 30-79
Guinea-Bissau
36
in 2019
Indonesia
35.9
in 2019
Guinea-Bissau rank
111th
Indonesia rank
114th
Prevalence rate of hypertension in men aged 30-79 over time
- Guinea-Bissau
- Indonesia
How they compare
Guinea-Bissau currently reports 36 against 35.9 in Indonesia, a difference of 0.1.
Across all 30 years both countries report, Guinea-Bissau has been ahead every year.
Guinea-Bissau ranks 111th and Indonesia ranks 114th of 195 countries.
Guinea-Bissau has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 37.37 | 29.38 | 7.99 | Guinea-Bissau |
| 2000s | 38.7 | 31.57 | 7.13 | Guinea-Bissau |
| 2010s | 37.38 | 34.43 | 2.95 | Guinea-Bissau |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Guinea-Bissau or Indonesia?
- Guinea-Bissau, at 36 against 35.9 in Indonesia as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Guinea-Bissau and Indonesia?
- 0.1, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and Indonesia?
- 30 years are reported by both, from 1990 to 2019.
- How do Guinea-Bissau and Indonesia rank globally for prevalence rate of hypertension in men aged 30-79?
- Guinea-Bissau ranks 111th and Indonesia ranks 114th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.